The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

The Scientist Placeholder Image

D For Winners

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

Medal Of Science Winners: Eight Pioneers Of Research

The Scientist Placeholder Image

Neuroscience Is A Booming Field--For Neuroscientists With Jobs, That Is

The Scientist Placeholder Image

NIH Fraud Investigators Take On New Roles At Agency, But Remain Determined To Resume Sleuthing Activity

The Scientist Placeholder Image

Sex Discrimination Controversies Continue To Plague Health Agency

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

With Five-Year Ban On Fetal Tissue Studies Lifted, Scientists Are Striving To Make Up For Lost Time

The Scientist Placeholder Image

Gene Therapy: Clinical Gains Yield A Wealth Of Research Opportunities

The Scientist Placeholder Image

Society Presidents' Council Mobilizes For Dynamic Role In Reshaping Science

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

NSF Study Finds Many Teachers Unprepared For Instructing Children In The Sciences

Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies